Table 3.
Biochemical assessment at baseline and during hospitalization in the active and control groups.
| Variable – median (IQR) | Active group (N = 101) | Control group (N = 92) | Reference value | p-Value |
|---|---|---|---|---|
| Leukocytes (mm3) | ||||
| Baseline | 6000 (4900−7360) | 5200 (4400−6950) | 4000−11,300 | >0.05 |
| Peak | 7800 (6300−9900) | 7200 (5500−9400) | >0.05 | |
| Lymphocytes (mm3) | ||||
| Baseline | 1260 (840−1620) | 1144 (780−1404) | 1000−4800 | >0.05 |
| Nadir | 1050 (654−1344) | 868 (624−1180) | >0.05 | |
| Fibrinogen (mg/dL) | ||||
| Baseline | 497 (401−627) | 353 (297−524) | 220−496 | >0.05 |
| Peak | 496 (401−657) | 352 (297−524) | >0.05 | |
| D-dimer (ng/mL) | ||||
| Baseline | 758 (463−1236) | 753 (520−1227) | <500 | >0.05 |
| Peak | 1193 (797−1844) | 1047 (645−2228) | >0.05 | |
| LDH (U/L) | ||||
| Baseline | 497 (401−627) | 273 (221−358) | 120−246 | >0.05 |
| Peak | 346 (287−444) | 301 (239−375) | <0.05 | |
| Baseline troponin (ng/L) | 4 (2−10) | 6 (2−13) | <19 | >0.05 |
| AST (U/L) | ||||
| Baseline | 38 (29−61) | 45 (36−60) | 14−36 | >0.05 |
| Peak | 49 (40−66) | 50 (30−69) | >0.05 | |
| ALT (U/L) | ||||
| Baseline | 31 (19−48) | 42 (25−58) | <35 Women | >0.05 |
| Peak | 48 (28−71) | 38 (23−55) | <50 Men | >0.05 |
| CRP (mg/dL) | ||||
| Baseline | 6 (3−15) | 9 (5−19) | <1 | <0.05 |
| Peak | 16 (6−24) | 9 (5−21) | <0.05 | |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; LDH, lactate dehydrogenase.